Tissue-specific damage in expression and function of breast cancer resistance protein in streptozotocin-induced diabetic rats

Journal of China Pharmaceutical University

Volumn 42, Issue 6, 2011, Pages 544-550

  Zhang, Lu Lu ^a   Jin, Shi ^a   Li, Jia ^a   Duan, Ru ^a   Liu, Xiao Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Breast cancer resistance protein; Diabetes mellitus; Expression and function; Prazosin; Tissue specificity

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; INSULIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BREAST CANCER; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GLUCOSE BLOOD LEVEL; HIPPOCAMPUS; INTESTINE MUCOSA; KIDNEY; LIVER; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TISSUE SPECIFICITY; WESTERN BLOTTING;

EID: 84862908857     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kasichayanula S, Chang M, Hasegawa M, et al. Pharmacokinetics and pharmacodynamics of dapagliflozin, a novel selective inhibitor of sodium-glucose co-transporter type 2, in Japanese subjects without and with type 2 diabetes mellitus [J]. Diabetes Obes Metab, 2011,13(4):357-365.
2. Ikarashi N, Kagami M, Kobayashi Y, et al. Changes in the pharmacokinetics of digoxin in polyuria in streptozotocin-induced diabetic mice and lithium carbonate-treated mice [J]. Xenobiotica, 2011, 41(6):486-493.
3. Kim YC, Oh EY, Kim SH, et al. Pharmacokintics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin [J]. Biopharm Drug Dispos, 2006,27(2):85-92.
4. An G, Wu F, Morris ME. 5,7-Dimethoxyflavone and multiple flavonoids in combination alter the ABCG2-mediated tissue distribution of mitoxantrone in mice[J]. Pharm Res, 2011,28(5):1 090-1 099.
5. Liu H, Zhang D, Xu X, et al. Attenuated function and expression of P-glycoprotein at blood-brain barrier and increased brain distribution of phenobarbital in streptozotocin-induced diabetic mice [J]. Eur J Pharmacol, 2001,561(1/2/3):226-232.
6. Liu W, Saint DA. Validation of a quantitative method for real time PCR kinetics[J]. Biochem Biophys Res Commun, 2002,294(2):347-353.
7. Applied-Biosystems. Relative quantitation of gene expression. User bulletin # 2. ABI PRISM 7700 sequence detection system [J]. 1997.
8. Jing X, Liu X, Wen T, et al. Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats[ J]. Br J Pharmacol, 2010,159(7):1 511-1 522.
9. Liu YC, Liu HY, Yang HW, et al. Impaired expression and function of breast cancer resistance protein (Bcrp) in brain cortex of streptozocin-induced diabetic rats[J]. Biochem Pharmacol, 2007,74(12):1 766-1 772.
10. Liu X, Jing XY, Jin S, et al. Insulin suppressed expression and function of breast cancer resistance protein in primarily cultured rat brain microvessel endothelial cells[J]. Pharmacol Rep, 62(2):487-493.
11. Grunnet LG, Mandrup-Poulsen T. Cytokines and type 1 diabetes: a numbers game[J]. Diabetes, 2011,60(3):697-699.
12. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress [J]. Circulation, 2002,106(16):2 067-2 072.
13. Elahian F, Kalalinia F, Behravan J. Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines [J]. Oncol Res, 2009,18(1):9-15.
14. Sakata S, Fujiwara M, Ohtsuka K, et al. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells[J]. Oncol Rep, 2011,25(2):333-339.
15. Yin Y, Yang M, Wang Y, et al. Tanshinone IIA increases mRNA expression of efflux transporters in cultured human intestinal cell [J]. Am J Chin Med, 2010,38(5):995-1 004.
16. Enokizono J, Kusuhara H, Sugiyama Y. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the biliary excretion and intestinal efflux of troglitazone sulfate, the major metabolite of troglitazone with a cholestatic effect[J]. Drug Metab Dispos, 2007,35(2):209-214.
17. Meng Q, Liu Q, Wang C, et al. Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters[J]. Drug Metab Pharmacokinet, 2010,25(4):320-327.
18. Schwabedissen HE, Kroemer HK. In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ ABCG2) [J]. Handb Exp Pharmacol, 2011(201):325-371.